Drug repositioning of TANK-binding kinase 1 inhibitor CYT387 as an alternative for the treatment of Gram-negative bacterial sepsis.

MLA

Lee, Seung Jun, et al. “Drug Repositioning of TANK-Binding Kinase 1 Inhibitor CYT387 as an Alternative for the Treatment of Gram-Negative Bacterial Sepsis.” International Immunopharmacology, vol. 73, Aug. 2019, pp. 482–90. EBSCOhost, https://doi.org/10.1016/j.intimp.2019.05.051.

APA

Lee, S. J., Gharbi, A., You, J. S., Han, H. D., Kang, T. H., Hong, S. H., Park, W. S., Jung, I. D., & Park, Y.-M. (2019). Drug repositioning of TANK-binding kinase 1 inhibitor CYT387 as an alternative for the treatment of Gram-negative bacterial sepsis. International Immunopharmacology, 73, 482–490. https://doi.org/10.1016/j.intimp.2019.05.051

Chicago

Lee, Seung Jun, Amal Gharbi, Jueng Soo You, Hee Dong Han, Tae Heung Kang, Seong Hwi Hong, Won Sun Park, In Duk Jung, and Yeong-Min Park. 2019. “Drug Repositioning of TANK-Binding Kinase 1 Inhibitor CYT387 as an Alternative for the Treatment of Gram-Negative Bacterial Sepsis.” International Immunopharmacology 73 (August): 482–90. doi:10.1016/j.intimp.2019.05.051.